Related references
Note: Only part of the references are listed.Next Generation Sequencing Technology in Lung Cancer Diagnosis
Calin Cainap et al.
BIOLOGY-BASEL (2021)
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Katharina Schwarze et al.
GENETICS IN MEDICINE (2020)
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders
Patrick Fahr et al.
PHARMACOECONOMICS (2020)
Costs of in-house genomic profiling and implications for economic evaluation: a case example of non-small cell lung cancer (NSCLC)
Karissa M. Johnston et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
The use of micro-costing in economic analyses of surgical interventions: a systematic review
Shelley Potter et al.
HEALTH ECONOMICS REVIEW (2020)
Next-Generation Sequencing of Infectious Pathogens
Marta Gwinn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Clinical application of next-generation sequencing to the practice of neurology
Jessica Rexach et al.
LANCET NEUROLOGY (2019)
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study
Patricia Marino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
A time-and-motion approach to micro-costing of high-throughput genomic assays
S. Costa et al.
CURRENT ONCOLOGY (2016)
Next-generation sequencing approaches for the diagnosis of skeletal muscle disorders
Vincenzo Nigro et al.
CURRENT OPINION IN NEUROLOGY (2016)
Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis A Report of the Association for Molecular Pathology
Linda M. Sabatini et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms AMeta-analysis
Maria Schwaederle et al.
JAMA ONCOLOGY (2016)
Implementation of next generation sequencing in clinical molecular diagnostic laboratories: advantages, challenges and potential
Rajesh R. Singh et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2016)
Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis
Carlos J. Gallego et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma
Yonghong Li et al.
MOLECULAR DIAGNOSIS & THERAPY (2015)
Time motion studies in healthcare: What are we talking about?
Marcelo Lopetegui et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2014)
Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel
Douglas B. Johnson et al.
ONCOLOGIST (2014)
From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma
A. Thomas et al.
ANNALS OF ONCOLOGY (2013)
Using the time and motion method to study clinical work processes and workflow: methodological inconsistencies and a call for standardized research
Kai Zheng et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2011)
Cancer genomics: from discovery science to personalized medicine
Lynda Chin et al.
NATURE MEDICINE (2011)
Microcosting Quantity Data Collection Methods
Kevin D. Frick
MEDICAL CARE (2009)
Share Paper
